SECURITIES AND EXCHANGE COMMISSION
			  WASHINGTON, D.C. 20549


				 FORM 10-Q


		QUARTERLY REPORT UNDER SECTION 13 or 15(d)
		  OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended  June 30, 1995           Commission File Number  1-1687


			   PPG INDUSTRIES, INC.                            
	  (Exact name of registrant as specified in its charter)


	Pennsylvania                                         25-0730780    
(State or other jurisdiction of                          (I.R.S. Employer
 incorporation or organization)                         Identification No.)



One PPG Place, Pittsburgh, Pennsylvania                            15272   
(Address of principal executive offices)                         (Zip Code)




Registrant's telephone number, including area code      (412) 434-3131     



As of July 27, 1995, 202,841,950 shares of the Registrant's common stock, par 
value $1.66-2/3 per share, were outstanding.

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months, and (2) has been subject to such filing 
requirements for the past 90 days.


		    Yes   X                 No      








			   PPG INDUSTRIES, INC.
		       AND CONSOLIDATED SUBSIDIARIES
		       =============================


				   Index


Part I.  Financial Information                                        Page(s)


  Item 1.  Financial Statements:

    Condensed Statement of Operations................................       2

    Condensed Balance Sheet..........................................       3

    Condensed Statement of Cash Flows................................       4

    Notes to Condensed Financial Statements..........................   5 - 7

  Item 2.  Management's Discussion and Analysis of Financial
	   Condition and Results of Operations.......................  8 - 12


Part II.  Other Information


  Item 6.  Exhibits and Reports on Form 8-K..........................      13


Signature............................................................      14











 







				    - 1 -
 


		      Part I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

		     PPG INDUSTRIES, INC. AND SUBSIDIARIES

		 Condensed Statement of Operations (Unaudited)
		     (Millions, except per share amounts)

				     Three Months            Six Months
				     Ended June 30          Ended June 30
				    1995       1994        1995       1994
                                                        
Net sales.......................  $1,870.4   $1,619.3    $3,611.2   $3,096.2
Cost of sales...................   1,109.3      987.9     2,137.4    1,899.7
  Gross profit..................     761.1      631.4     1,473.8    1,196.5

Other expenses:
  Selling, general and
    administrative..............     258.2      223.4       489.7      439.5
  Depreciation..................      82.9       79.0       162.9      157.5
  Research and development......      59.3       54.5       116.2      103.4
  Interest......................      20.7       22.4        41.2       44.2
  Business divestiture (Note 3).       -         85.0         -         85.0
  Other charges.................      32.1       28.5        70.1       43.6

  Total other expenses..........     453.2      492.8       880.1      873.2

Other earnings..................      49.0       22.6       122.1       47.5

Income before income taxes
  and minority interest.........     356.9      161.2       715.8      370.8

Income taxes....................     135.6       60.9       272.0      144.7

Minority interest...............       4.5        4.1         7.8        8.0

Net income......................  $  216.8   $   96.2    $  436.0   $  218.1

Earnings per share..............  $   1.06   $   0.46    $   2.12   $   1.03

Dividends per share.............  $   0.29   $   0.28    $   0.58   $   0.55

Average shares outstanding......     205.2      212.4       205.8      212.7




The accompanying notes to the condensed financial statements are an integral 
part of this statement.





				    - 2 -



		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

		    Condensed Balance Sheet (Unaudited)

						  June 30       Dec. 31
						   1995           1994
							(Millions)
                                                         
Assets
Current assets:
  Cash and cash equivalents...................   $  100.6      $   62.1
  Receivables-net.............................    1,402.6       1,228.9
  Inventories (Note 2)........................      760.4         686.4
  Other.......................................      188.4         190.8
    Total current assets......................    2,452.0       2,168.2

Property (less accumulated depreciation of
  $3,590.3 million and $3,420.4 million)......    2,757.8       2,742.3
Investments...................................      200.1         277.4
Other assets..................................      767.5         706.0
    Total.....................................   $6,177.4      $5,893.9

Liabilities and Shareholders' Equity
Current liabilities:
  Short-term borrowings and current
    portion of long-term debt.................   $  370.0      $  370.7
  Accounts payable and accrued liabilities....    1,077.9       1,034.4
  Income taxes................................       64.8          19.4
    Total current liabilities.................    1,512.7       1,424.5

Long-term debt................................      652.8         773.4
Deferred income taxes.........................      317.4         302.7
Accumulated provisions........................      290.6         260.5
Other postretirement benefits.................      511.4         505.5
Minority interest.............................       76.8          70.3
    Total liabilities.........................    3,361.7       3,336.9

Shareholders' equity:
  Common stock (Note 7).......................      484.3         484.3
  Additional paid-in capital..................       70.0          67.5
  Retained earnings...........................    4,036.9       3,717.1
  Treasury stock..............................   (1,605.0)     (1,488.6)
  Unearned compensation.......................     (192.2)       (183.0)
  Minimum pension liability adjustment........       (1.7)         (1.7)
  Currency translation adjustment.............       23.4         (38.6)
    Total shareholders' equity................    2,815.7       2,557.0

    Total.....................................   $6,177.4      $5,893.9




The accompanying notes to the condensed financial statements are an integral 
part of this statement.



				    - 3 -
 


		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

	       Condensed Statement of Cash Flows (Unaudited)

						  Six Months Ended June 30
						    1995            1994
							 (Millions)
                                                             
Cash from operating activities...............      $ 462.2         $ 241.0

Investing activities:
   Capital spending..........................       (164.5)         (136.8)
   Reduction of investments..................        117.0             --   
   Other.....................................         13.0             9.0
	Cash used for investing activities...        (34.5)         (127.8)

Financing activities:
   Net change in borrowings with
     maturities of three months or less......        (97.4)            9.3
   Proceeds from other short-term debt.......         21.0            19.1
   Repayment of other short-term debt........        (45.9)          (12.6)
   Proceeds from long-term debt..............          8.1             3.8
   Repayment of long-term debt...............        (25.8)          (18.7)
   Loans to employee stock ownership plan....        (25.0)          (11.0)
   Repayment of loans by employee stock
     ownership plan..........................         15.7             9.3
   Purchase of treasury stock, net...........       (119.1)          (56.7)
   Dividends paid............................       (117.8)         (116.9)
	Cash used for financing activities...       (386.2)         (174.4)

Effect of currency exchange rate changes
  on cash and cash equivalents...............         (3.0)            1.8

Net increase (decrease) in cash
  and cash equivalents.......................         38.5           (59.4)

Cash and cash equivalents,
  beginning of period........................         62.1           111.9

Cash and cash equivalents,
  end of period..............................      $ 100.6         $  52.5





The accompanying notes to the condensed financial statements are an integral 
part of this statement.







				    - 4 -



		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

	    Notes to Condensed Financial Statements (Unaudited)


1.   Financial Statements

	The condensed financial statements included herein are unaudited.  In 
the opinion of management, these statements include all adjustments, 
consisting only of normal, recurring adjustments, necessary for a fair 
presentation of the financial position of PPG Industries, Inc. and 
consolidated subsidiaries (the Company or PPG) at June 30, 1995, and the 
results of their operations for the three- and six-month periods ended 
June 30, 1995 and 1994 and their cash flows for the six-month periods 
ended June 30, 1995 and 1994.  These condensed financial statements 
should be read in conjunction with the financial statements and notes 
thereto incorporated by reference in PPG's Annual Report on Form 10-K 
for the year ended December 31, 1994.

	The results of operations for the six months ended June 30, 1995 
are not necessarily indicative of the results to be expected for the full 
year.


2.   Inventories

	Inventories at June 30, 1995, and December 31, 1994, are detailed 
	below.


							 June 30     Dec. 31
							  1995        1994
							     (Millions)
                                                               
      Finished products and work in process............  $513.7      $462.7
      Raw materials....................................   132.5       111.9
      Supplies.........................................   114.2       111.8

	Total..........................................  $760.4      $686.4


	Most domestic and certain foreign inventories are valued using the 
	last-in, first-out method.  If the first-in, first-out method had been 
	used, inventories would have been $212.5 million and $199.2 million 
	higher at June 30, 1995 and December 31, 1994, respectively.


3.   Business Divestiture

	PPG's operating results reflect the impact of the Company's programs to 
divest businesses and activities not meeting strategic or performance 
objectives.  The 1994 charge pertains to the divestiture of the 
Biomedical Systems Division.  Refer to Management's Discussion and 
Analysis of Financial Condition and Results of Operations for further 
details regarding this charge.



				    - 5 -




4.   Cash Flow Information

	Cash payments for interest for the six months ended June 30, 1995 and 
1994 were $45.9 million and $49.9 million, respectively.  Cash payments 
for income taxes for the six months ended June 30, 1995 and 1994 were 
$186.5 million and $143.9 million, respectively.


5.   Business Segment Information


				   Three Months            Six Months
				   Ended June 30          Ended June 30
				  1995       1994        1995       1994
						(Millions)
                                                       
     Net Sales:
	  Coatings and Resins    $  757     $  695      $1,441     $1,316
	  Glass                     698        617       1,359      1,185
	  Chemicals                 415        307         811        595

	    Total                $1,870     $1,619      $3,611     $3,096

     Operating Income (Loss):
	  Coatings and Resins    $  143     $  143      $  272     $  267
	  Glass                     135         93         290        169
	  Chemicals                 103         35         196         71
	  Other (1)                  -         (85)         -         (85)
	    Total operating
	     income                 381        186         758        422

     Interest expense - net         (18)       (20)        (36)       (40)

     Other unallocated corporate
       expense - net                 (6)        (5)         (6)       (11)

     Income before income taxes
       and minority interest     $  357     $  161      $  716     $  371



	  (1)   Loss in 1994 represents the charge to divest the 
Biomedical Systems Division (see Note 3).


6.   Environmental Matters

Management of the Company anticipates that the resolution of the 
environmental contingencies discussed below, which will occur over an 
extended period of time, will not result in future annual charges to 
income that are significantly greater than those recorded in recent 
years.  It is possible, however, that technological, regulatory and 
enforcement developments, the results of environmental studies and other 
factors could alter this expectation.  In management's opinion, the 
     
				- 6 -

Company operates in an environmentally sound manner and the outcome of 
these environmental matters will not have a material effect on PPG's 
financial position or liquidity.  To date, compliance with federal, 
state and local requirements has not had a material impact on PPG's 
financial position, results of operations or liquidity.

It is PPG's policy to accrue expenses for environmental contingencies 
when it is probable that a liability exists and the amount of loss can 
be reasonably estimated.  As of June 30, 1995 and December 31, 1994, PPG 
had environmental reserves totaling $92 million and $90 million, 
respectively.  Charges against income for environmental remediation 
costs for the six month periods ended June 30, 1995 and 1994 were 
$21 million and $13 million, respectively.

In addition to the amounts accrued, the Company may be subject to 
contingencies related to environmental matters estimated at the high end 
to be as much as $200 million to $400 million.  Such aggregate losses 
are reasonably possible but not currently considered to be probable of 
occurrence.  The Company's current environmental contingencies are 
expected to be resolved over a period of 20 years or more.  These loss 
contingencies include significant unresolved issues such as the nature 
and extent of contamination, if any, at sites and the methods that may 
have to be employed should remediation be required.  Although insurance 
may cover a portion of these costs, to the extent they are incurred, any 
potential recovery is not included in this unrecorded exposure to future 
loss.  With respect to certain waste sites, the financial condition of 
any other potentially responsible parties also contributes to the 
uncertainty of estimating PPG's final costs.  Although contributors of 
waste to sites involving other potentially responsible parties may face 
governmental agency assertions of joint and several liability, in 
general, final allocations of costs are made based on the relative 
contributions of wastes to such sites.  PPG is generally not a major 
contributor to such sites.  Although the unrecorded exposure to future 
loss relates to all sites, a significant portion of such unrecorded 
exposure involves three operating plant sites and one closed plant site. 
Two of the sites are in the early stages of study, while the remaining 
two are further into the study phase.  All four sites require additional 
study to assess the magnitude of contamination, if any, and the 
remediation alternatives.


7.   Common Stock

On April 20, 1995, the Company's Restated Articles of Incorporation were 
amended to increase the number of authorized shares of common stock from 
300 million to 600 million.









				    - 7 -



 Item 2.  Management's Discussion and Analysis of Financial
	  Condition and Results of Operations

Performance in the Second Quarter of 1995 Compared to the Second Quarter of 
1994

Performance Overview

Sales for the second quarter of 1995 and 1994 were $1.87 billion and $1.62 
billion, respectively.  The sales increase was attributable to higher prices 
in all product lines, particularly for our chlor-alkali and derivative, fiber 
glass, and flat glass products, higher volumes in each of the business 
segments, and the favorable effects of foreign currency translation.

The gross profit percentage increased to 40.7% from 39.0% in the prior year's 
quarter primarily due to higher sales prices in all business segments.  The 
negative effects of inflation partially offset these gains.

Net income and earnings per share for the 1995 quarter were $216.8 million and 
$1.06, respectively.  In the second quarter of 1994, net income and earnings 
per share were $96.2 million and $0.46, respectively, which included a $52 
million ($0.24 per share) after-tax charge to divest the Biomedicals Systems 
Division.  Current period net income was favorably impacted by the factors 
that contributed to the gross profit percentage improvement, higher sales 
volumes, the absence of the business divestiture charge, and increased other 
earnings which were attributable to gains from legal settlements.  Partially 
offsetting these gains was higher income tax expense.

Performance of Business Segments

Coatings and resins sales increased to $757 million from $695 million in the 
second quarter of 1994.  Operating earnings for both periods were 
$143 million.  The increase in sales was primarily attributable to higher 
volumes in all European product lines, particularly automotive products, the 
favorable effects of translating European currencies, higher volumes for North 
American architectural coatings, and stronger prices worldwide for our 
automotive refinish products.  The effect of lower North American automotive 
refinish volume partially offset these improvements. Despite higher sales, 
operating earnings remained flat as the favorable effects of volume 
improvements and manufacturing efficiencies, combined with a gain from a legal 
settlement, were offset by the negative effects of inflation, particularly on 
raw material costs.

Glass sales increased to $698 million in the second quarter of 1995 from $617 
million in the prior year's quarter.  Operating income increased to $135 
million from $93 million in the corresponding 1994 period.  Contributing to 
the sales increase were higher sales prices, principally for worldwide flat 
glass and fiber glass products and North American automotive replacement 
glass, the favorable effects of translating European currencies, and higher 
fiber glass volume.  The effect of lower North American automotive replacement 
glass volume partially offset these improvements.  Increased operating 
earnings were primarily the result of the factors that contributed to the 
sales increase, partially offset by the negative effects of inflation.


				    - 8 -

Chemicals sales increased to $415 million from $307 million in the second 
quarter of 1994.  Operating earnings for the corresponding periods were $103 
million and $35 million, respectively.  The increase in sales was primarily 
attributable to substantial price gains for chlor-alkali and derivative 
products and higher volumes for Transitions optical lenses.  The increase in 
operating earnings was attributable to the factors that contributed to the 
sales increase, partially offset by the negative effects of inflation, 
particularly on ethylene costs, and higher overhead costs.

The "other" segment's 1994 operating loss represents the charge to divest the 
Biomedical Systems Division.

Performance in the First Six Months of 1995 Compared to the First Six Months 
of 1994

Performance Overview

Sales for the first six months of 1995 and 1994 were $3.61 billion and $3.10 
billion, respectively.  The sales increase was attributable to higher prices 
in all product lines, particularly for our chlor-alkali and derivative, fiber 
glass, and flat glass products, higher volumes in each of the business 
segments, and the favorable effects of foreign currency translation.

The gross profit percentage increased to 40.8% from 38.6% in the prior year 
primarily due to higher sales prices in all business segments.  The negative 
effects of inflation partially offset these gains.

Net income and earnings per share for the current year period were $436.0 
million and $2.12, respectively, which included a $24.2 million after-tax gain 
($0.12 per share) from a legal settlement of a glass technology dispute with 
Pilkington plc of England.  In the prior year period, net income and earnings 
per share were $218.1 million and $1.03, respectively, including a $52 million 
($0.24 per share) after-tax charge to divest the Biomedical Systems Division.  
Current period earnings were favorably impacted by the factors that 
contributed to the gross profit percentage improvement, higher sales volumes, 
the absence of the business divestiture charge, and increased other earnings 
which were attributable to several gains from legal settlements.  Partially 
offsetting these items were higher income tax expense and increased other 
charges.  The majority of the increase in other charges was the result of a 
charge for a legal dispute and higher environmental expense.

Performance of Business Segments

Coatings and resins sales increased to $1.44 billion from $1.32 billion in the 
first six months of 1994.  Operating earnings for the corresponding periods 
were $272 million and $267 million, respectively.  Contributing to the sales 
increase were higher volumes in all European product lines, particularly 
automotive products, the favorable effects of translating European currencies, 
higher volumes in North American industrial and architectural coatings, and 
stronger prices in our automotive refinish products.  The effect of lower 
North American automotive refinish volume partially offset these improvements. 
     


				    - 9 -

Despite higher sales, operating earnings remained relatively flat as the 
effects of higher volumes, combined with gains from legal settlements, were 
substantially offset by the negative effects of inflation, particularly on raw 
material costs.

Glass sales increased to $1.36 billion in the sixth-month period ended June 
30, 1995, from $1.19 billion in the prior year period.  Operating income 
increased to $290 million from $169 million in the corresponding 1994 period. 
Contributing to the sales increase were higher sales prices, principally for 
worldwide fiber glass and flat glass products, higher volumes in most of the 
segment's major businesses, principally worldwide fiber glass and automotive 
original, and the favorable effects of translating European currencies.  The 
effect of lower volume in North American automotive replacement glass 
partially offset these improvements.  Increased operating earnings were 
primarily the result of the factors that contributed to the sales increase and 
the gain from the first quarter legal settlement with Pilkington.  The 
negative effects of inflation and higher overhead costs partially offset these 
improvements.

Chemicals sales increased to $811 million from $595 million for the six-month 
period ended June 30, 1995.  Operating income increased to $196 million from 
$71 million for the corresponding prior year period.  The increase in sales 
was primarily attributable to substantial price gains for chlor-alkali and 
derivative products and volume improvements for specialty products, 
particularly Transitions optical lenses.  The increase in operating earnings 
was attributable to the factors that contributed to the sales increase.  
Partially offsetting these improvements were the negative effects of 
inflation, particularly on ethylene costs, a charge for a legal dispute, 
increased environmental expenses, and higher overhead costs.

The "other" segment's 1994 operating loss represents the charge to divest the 
Biomedical Systems Division.

Other Factors

The increase in income tax expense was principally due to significantly higher 
pre-tax earnings.

The increase in accounts receivable was the result of higher sales in May and 
June of 1995 as compared with those in November and December of 1994, seasonal 
extended credit terms to certain customers, and the strengthening of certain 
European currencies against the U.S. dollar.

Higher inventories were mainly due to a build-up in our coatings and resins 
segment, primarily in Europe, to support stronger sales volumes.  Also 
contributing to the increase was the strengthening of certain European 
currencies against the U.S. dollar.

The decline in investments was principally due to a loan taken against the 
cash surrender value of an investment in company-owned life insurance.

A pension plan contribution was the main factor contributing to the increase 
in other assets.


				    - 10 -


Environmental Matters

Management of the Company anticipates that the resolution of the environmental 
contingencies discussed below, which will occur over an extended period of 
time, will not result in future annual charges to income that are 
significantly greater than those recorded in recent years.  It is possible, 
however, that technological, regulatory and enforcement developments, the 
results of environmental studies and other factors could alter this 
expectation.  In management's opinion, the Company operates in an 
environmentally sound manner and the outcome of these environmental matters 
will not have a material effect on PPG's financial position or liquidity.  To 
date, compliance with federal, state and local requirements has not had a 
material impact on PPG's financial position, results of operations or 
liquidity.

It is PPG's policy to accrue expenses for environmental contingencies when it 
is probable that a liability exists and the amount of loss can be reasonably 
estimated.  As of June 30, 1995 and December 31, 1994, PPG had environmental 
reserves totaling $92 million and $90 million, respectively. Charges against 
income for environmental remediation costs for the six month periods ended 
June 30, 1995 and 1994 were $21 million and $13 million, respectively.

In addition to the amounts accrued, the Company may be subject to 
contingencies related to environmental matters estimated at the high end to be 
as much as $200 million to $400 million.  Such aggregate losses are reasonably 
possible but not currently considered to be probable of occurrence.  The 
Company's current environmental contingencies are expected to be resolved over 
a period of 20 years or more.  These loss contingencies include significant 
unresolved issues such as the nature and extent of contamination, if any, at 
sites and the methods that may have to be employed should remediation be 
required.  Although insurance may cover a portion of these costs, to the 
extent they are incurred, any potential recovery is not included in this 
unrecorded exposure to future loss.  With respect to certain waste sites, the 
financial condition of any other potentially responsible parties also 
contributes to the uncertainty of estimating PPG's final costs.  Although 
contributors of waste to sites involving other potentially responsible parties 
may face governmental agency assertions of joint and several liability, in 
general, final allocations of costs are made based on the relative 
contributions of wastes to such sites.  PPG is generally not a major 
contributor to such sites.  Although the unrecorded exposure to future loss 
relates to all sites, a significant portion of such unrecorded exposure 
involves three operating plant sites and one closed plant site. Two of the 
sites are in the early stages of study, while the remaining two are further 
into the study phase.  All four sites require additional study to assess the 
magnitude of contamination, if any, and the remediation alternatives.









				    - 11 -

Business Divestiture

PPG's operating results reflect the impact of the Company's programs to divest 
businesses and activities not meeting strategic or performance objectives.  
The 1994 charge pertains to the divestiture of the Biomedicals System 
Division.  The majority of the charge was comprised of the reversal of a $60 
million gain originally anticipated from divestiture of the division's sensors 
business at the time the decision was made to dispose of the division and 
reflects the general decline in health-care and related markets.  Also, a $13 
million charge was taken for additional operating losses anticipated because 
of extension of the expected disposal date as well as actual operating losses 
exceeding those originally estimated.  With the sale of the sensors business 
in January 1995, the divestiture of the Biomedical Systems Division is 
complete.

Foreign Currency and Interest Rate Risk

As a multinational company, PPG manages its transaction exposure to foreign 
currency risk to minimize the volatility of cash flows caused by currency 
fluctuations.  The Company manages its foreign currency exposures principally 
through the purchase of forward and option contracts.  It does not manage its 
exposure to translation gains and losses; however, by borrowing in local 
currencies it reduces such exposure.  The market value of the forward and 
option contracts purchased and outstanding as of June 30, 1995, was not 
material.

The Company manages its interest rate risk in order to balance its exposure 
between fixed and variable rates while attempting to minimize its interest 
costs.  PPG principally manages its interest rate risk by retiring and issuing 
debt from time to time.  To a limited extent, PPG manages its interest rate 
risk through the purchase of interest rate swaps.  As of June 30, 1995 and 
December 31, 1994, the notional principal amounts and fair values of interest 
rate swaps held were immaterial.

PPG's policies do not permit active trading of currency or interest rate 
derivatives.



















				    - 12 -

		      Part II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

     (a)  Exhibits

	  (10)  Settlement Agreement

	  (11)  Computation of Earnings Per Share

	  (27)  Financial Data Schedule

     (b)  Reports on Form 8-K

The Company filed a Form 8-K on April 7, 1995, dated April 4, 1995, 
attaching a press release.  The release indicated that the glass 
technology dispute with Pilkington plc of England had been settled. 
Both companies dismissed all actions on the basis of no finding of 
fault on either side.  Pilkington plc is to pay PPG $50 million, 
being reimbursement of $36 million paid by PPG to Pilkington after 
an earlier litigation and a contribution toward balancing of legal 
costs.  This settlement eliminates all existing claims between PPG 
and Pilkington and those companies agreed generally not to file any 
future claims against each other, or their subsidiaries or 
licensees, concerning float-process technology for making flat 
glass.

The Company filed a Form 8-K on April 24, 1995, dated April 20, 
1995.  The report indicated that on April 20, 1995 the Board of 
Directors approved the repurchase of ten million shares of the 
Company's outstanding common stock, par value $1.66 2/3 per share. 
The shares may be repurchased in open market or private 
transactions and a timetable was not established for the 
repurchase.





















				    - 13 -


				 SIGNATURE





Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.





						  PPG INDUSTRIES, INC.     
						      (Registrant)





Date:    July 31, 1995                          /s/ W. H. Hernandez        
						    W. H. Hernandez      
					     Senior Vice President, Finance
					      (Principal Financial and
					       Accounting Officer and
					       Duly Authorized Officer)



























				    - 14 -


		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

			     INDEX TO EXHIBITS



Exhibit
  No.              Description             


  (10)      Settlement Agreement

  (11)      Computation of Earnings Per Share

  (27)      Financial Data Schedule